Project Aim

A new study Resurgence of rheumatic fever among Pacific Peoples in Aotearoa New Zealand: a 2010-2023 analysis of hospitalisation data with implications for equity policy published by Pacific Perspectives, analyses national hospitalisation and mortality data for acute rheumatic fever (ARF) and rheumatic heart disease (RHD) between 2010 and 2023. 

​

The research reveals persistent and worsening ethnic and geographic inequities. ARF remains overwhelmingly concentrated among Pacific and Māori populations, with the highest burden seen in Pacific peoples in specific high-burden areas like Counties Manukau and the Ōtara-Papatoetoe Locality. These cases frequently occur in the most socioeconomically deprived communities. 

​

Key Findings Highlight a widening Gap 

​

• Failure of Prevention: Despite major, long-term investment, the overall incidence of ARF among Pacific peoples has increased over time. While Māori experienced a slight but statistically significant decline during the Rheumatic Fever Prevention Programme that was not seen among Pacific peoples. The government’s 2012 incidence target has never been met for both groups with incidence remaining high for both. 

• Highest Recorded Cases: After a sharp temporary decline observed only among Pacific peoples during COVID-19 restrictions, cases have rebounded strongly. Alarmingly, 2024 recorded the highest number of Pacific cases ever reported. 

This research provides a critical evidence base for future policy and highlights the need for stronger national leadership, consistent surveillance, and sustained, equity-focused action to achieve the goals of the Pae Ora (Healthy Futures) Act 2022.